Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immunoglobulin Light-chain Amyloidosis × pegfilgrastim × 90 days × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 4 Breast Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Hodgkin Disease 2 Burkitt Lymphoma 2 Triple Negative Breast Neoplasms 1 Teratoma 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pain 1 Osteosarcoma 1 Neoplasms 1 Medulloblastoma 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Infiltrating Bladder Urothelial Carcinoma 1 Heart Failure 1 Glioma 1 Fallopian Tube Neoplasms 1 Desmoplastic Small Round Cell Tumor 1 Dendritic Cell Sarcoma, Interdigitating 1 Choriocarcinoma 1 Central Nervous System Neoplasms 1 Cardiotoxicity 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Embryonal 1

Interventions

Dexamethasone 8 Bortezomib 5 Cyclophosphamide 4 daratumumab 3 venetoclax 2 belantamab mafodotin 2 X-Rays 2 Specimen Handling 2 Phantoms, Imaging 2 Clinical Protocols 2 pomalidomide 1 ixazomib 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 Valganciclovir 1 Therapeutics 1 Polymerase Chain Reaction 1 Pharmaceutical Preparations 1 Magnetic Resonance Spectroscopy 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Calcium Dobesilate 1 Biopsy 1 Antiviral Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡